Suppr超能文献

一名接受长期阿昔洛韦治疗的艾滋病患者中出现对阿昔洛韦耐药的水痘带状疱疹病毒。

Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy.

作者信息

Linnemann C C, Biron K K, Hoppenjans W G, Solinger A M

机构信息

Department of Medicine, University of Cincinnati College of Medicine, Ohio 45267-0560.

出版信息

AIDS. 1990 Jun;4(6):577-9. doi: 10.1097/00002030-199006000-00014.

Abstract

We demonstrate for the first time the appearance of acyclovir resistance in serial varicella zoster isolates from a patient treated with acyclovir. We recovered varicella zoster virus three times over a period of 5 months from the skin lesions of this patient with AIDS who was treated with three courses of intravenous acyclovir and prolonged low-dose oral acyclovir. The isolate recovered from a typical zoster lesion before acyclovir, and one obtained from a hyperkeratotic lesion 2 months later, after intravenous and oral acyclovir, were sensitive to acyclovir and produced normal amounts of thymidine kinase. In contrast, virus recovered from lesions 5 months after the onset, when the patient had received repeated courses of acyclovir, was acyclovir-resistant and thymidine-kinase-deficient. Resistance to acyclovir was associated with persistence of lesions which failed to improve with intravenous acyclovir, but was not associated with new lesion formation.

摘要

我们首次证明了在接受阿昔洛韦治疗的患者的系列水痘带状疱疹分离株中出现了阿昔洛韦耐药性。在5个月的时间里,我们从一名接受了三个疗程静脉注射阿昔洛韦和长期低剂量口服阿昔洛韦治疗的艾滋病患者的皮肤损伤中三次分离出水痘带状疱疹病毒。在使用阿昔洛韦之前从典型带状疱疹损伤中分离出的毒株,以及在静脉注射和口服阿昔洛韦2个月后从角化过度损伤中获得的毒株,对阿昔洛韦敏感,并产生正常量的胸苷激酶。相比之下,在发病5个月后从损伤中分离出的病毒,此时患者已接受了多次阿昔洛韦疗程,对阿昔洛韦耐药且胸苷激酶缺乏。对阿昔洛韦的耐药性与损伤持续存在有关,静脉注射阿昔洛韦后损伤未能改善,但与新损伤形成无关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验